Skip to main content
Livermore
Livermore
ZHEN

HM Payson & Co

SEC CIK
0000928052
Latest filing
Jul 17, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q2 2026)
2,320
Value
$126.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CRSP by HM Payson & Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,320$126.5K<0.1%−1,000−30.1%ReducedHolders
Q1 20263,320$157.9K<0.1%+1,000+43.1%AddedHolders
Q4 20252,320$121.7K<0.1%00.0%UnchangedHolders
Q3 20252,320$150.4K<0.1%−10−0.4%ReducedHolders
Q2 20252,330$113.3K<0.1%00.0%UnchangedHolders
Q1 20252,330$79.3K<0.1%00.0%UnchangedHolders
Q4 20242,330$91.7K<0.1%00.0%UnchangedHolders
Q3 20242,330$109.5K<0.1%+1,250+115.7%AddedHolders
Q2 20241,080$58.3K<0.1%00.0%UnchangedHolders
Q1 20241,080$73.6K<0.1%+100+10.2%AddedHolders
Q4 2023980$61.3K<0.1%00.0%UnchangedHolders
Q3 2023980$44.5K<0.1%00.0%UnchangedHolders
Q2 2023980$55.0K<0.1%00.0%UnchangedHolders
Q1 2023980$44.3K<0.1%00.0%UnchangedHolders
Q4 2022980$39.8K<0.1%+500+104.2%AddedHolders
Q3 2022480$31.0K<0.1%+400+500.0%AddedHolders
Q2 202280$5.00K<0.1%00.0%UnchangedHolders
Q1 202280$5.00K<0.1%00.0%UnchangedHolders
Q4 202180$6.00K<0.1%−25−23.8%ReducedHolders
Q3 2021105$12.0K<0.1%+28+36.4%AddedHolders
Q2 202177$12.0K<0.1%+42+120.0%AddedHolders
Q1 202135$4.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.